CRMD · CorMedix Inc. · Documents
$7.57
+0.19 (+2.57%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$590.04M
Shares
77.94M
Volume · Oct 20
971.66K
Avg daily vol (3M)
1.12M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | CorMedix announced the FDA accepted for Priority Review a supplemental New Drug Application for REZZAYO (rezafungin) seeking approval for prophylaxis of invasive fungal disease, with a PDUFA target action date in Q1 2027. | 2026-10-19 | — | |
| Investor Event Transcript | — | 2026-09-09 | 2026-09-30 | |
| 10-Q | — | 2026-08-13 | 2026-06-30 | |
| 8-K | — | 2026-08-13 | — | |
| 8-K | — | 2026-08-07 | — | |
| 8-K | — | 2026-07-02 | 2026-06-29 | |
| 8-K | — | 2026-07-01 | 2026-06-25 | |
| 8-K | — | 2026-06-24 | 2026-06-23 | |
| 8-K | — | 2026-06-08 | — | |
| 8-K | — | 2026-05-14 | — | |
| 10-Q | — | 2026-05-14 | 2026-03-31 | |
| ARS | — | 2026-04-29 | 2025-12-31 | |
| DEF 14A | — | 2026-04-29 | 2026-06-23 | |
| DEFA14A | — | 2026-04-29 | — | |
| 8-K | — | 2026-04-27 | — | |
| PRE 14A | — | 2026-04-17 | — | |
| 8-K | — | 2026-03-06 | — | |
| 8-K | — | 2026-03-05 | — | |
| 10-K | — | 2026-03-05 | 2025-12-31 | |
| 8-K | — | 2026-01-08 | 2026-01-05 | |
| 8-K | — | 2025-11-12 | — | |
| 10-Q | — | 2025-11-12 | 2025-09-30 | |
| DEF 14A | — | 2025-10-24 | 2025-11-10 | |
| 8-K | — | 2025-10-20 | — | |
| S-3ASR | — | 2025-10-07 | — | |
| S-3ASR | — | 2025-10-06 | — | |
| 8-K/A | — | 2025-09-30 | 2025-08-29 | |
| S-3 | — | 2025-09-30 | — | |
| PRE 14A | — | 2025-09-15 | — | |
| 8-K | — | 2025-09-02 | 2025-08-28 | |
| 8-K | — | 2025-08-12 | — | |
| 10-Q | — | 2025-08-07 | 2025-06-30 | |
| 8-K | — | 2025-08-07 | 2025-08-06 | |
| 8-K | — | 2025-06-30 | 2025-06-26 | |
| 8-K | — | 2025-06-25 | 2025-06-24 | |
| 8-K | — | 2025-06-23 | — | |
| 10-Q | — | 2025-05-06 | 2025-03-31 | |
| 8-K | — | 2025-05-06 | — | |
| DEF 14A | — | 2025-04-28 | 2025-06-24 | |
| DEFA14A | — | 2025-04-28 | — | |
| ARS | — | 2025-04-28 | 2024-12-31 | |
| 8-K | — | 2025-04-22 | 2025-04-17 | |
| 8-K | — | 2025-04-08 | — | |
| 10-K | — | 2025-03-25 | 2024-12-31 | |
| 8-K | — | 2025-03-25 | — | |
| 8-K | — | 2025-01-07 | — | |
| 8-K | — | 2024-11-25 | 2024-11-21 | |
| 8-K | — | 2024-10-30 | — | |
| 10-Q | — | 2024-10-30 | 2024-09-30 | |
| DEF 14A | — | 2024-10-08 | 2024-11-21 |
Showing 1–50 of 143 filings
Key facts
CIK
1410098
CUSIP
21900C308
13F (30d)
13 filings
13 filers
Visit website
Investor relations